HUP0203721A2 - Új hormonkészítmény és alkalmazása - Google Patents
Új hormonkészítmény és alkalmazásaInfo
- Publication number
- HUP0203721A2 HUP0203721A2 HU0203721A HUP0203721A HUP0203721A2 HU P0203721 A2 HUP0203721 A2 HU P0203721A2 HU 0203721 A HU0203721 A HU 0203721A HU P0203721 A HUP0203721 A HU P0203721A HU P0203721 A2 HUP0203721 A2 HU P0203721A2
- Authority
- HU
- Hungary
- Prior art keywords
- dose
- hormonal composition
- progestogen
- component
- estrogen
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000003054 hormonal effect Effects 0.000 title 1
- 239000000583 progesterone congener Substances 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
A találmány tárgya gyógyszerészeti hormonkészítmények, amelyekorálisan adagolhatók, kombinált ösztrogén-progesztogén keverékbőlállnak, amelyek lehetővé teszik egy ösztrogén komponens 0,3-3 mgközötti dózisban történő és egy 19-norprogeszteron-származékprogesztogén komponens 0,3-1 ,5 mg közötti dózisban történő egyidejűadagolását egy vagy több nemtoxikus, inert, gyógyszerészetilegalkalmazható hordozóanyaggal együtt vagy azzal összekeverve. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/FR1999/002588 WO2001030356A1 (fr) | 1999-10-25 | 1999-10-25 | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
PCT/FR2000/002939 WO2001030357A1 (fr) | 1999-10-25 | 2000-10-24 | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP0203721A2 true HUP0203721A2 (hu) | 2003-03-28 |
HUP0203721A3 HUP0203721A3 (en) | 2003-07-28 |
HU229382B1 HU229382B1 (hu) | 2013-11-28 |
Family
ID=9542727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0203721A HU229382B1 (hu) | 1999-10-25 | 2000-10-24 | Egy ösztrogénen és nomegesztrol acetáton alapuló hormonkészítmény alkalmazása |
Country Status (27)
Country | Link |
---|---|
US (2) | US8168619B1 (hu) |
EP (1) | EP1227814B1 (hu) |
JP (1) | JP5036943B2 (hu) |
KR (1) | KR100623788B1 (hu) |
CN (1) | CN100553637C (hu) |
AP (1) | AP1625A (hu) |
AT (1) | ATE286400T1 (hu) |
AU (1) | AU777704B2 (hu) |
BR (1) | BRPI0014979B8 (hu) |
CA (1) | CA2389025C (hu) |
CZ (1) | CZ303248B6 (hu) |
DE (1) | DE60017281T2 (hu) |
DK (1) | DK1227814T3 (hu) |
ES (1) | ES2235967T3 (hu) |
HK (1) | HK1050472B (hu) |
HU (1) | HU229382B1 (hu) |
IL (2) | IL148953A0 (hu) |
MX (1) | MXPA02004084A (hu) |
NO (1) | NO327973B1 (hu) |
NZ (1) | NZ518145A (hu) |
OA (1) | OA12072A (hu) |
PL (1) | PL199848B1 (hu) |
PT (1) | PT1227814E (hu) |
RU (1) | RU2261106C2 (hu) |
SI (1) | SI1227814T1 (hu) |
WO (2) | WO2001030356A1 (hu) |
ZA (1) | ZA200203398B (hu) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
WO2001030356A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
FR2814074B1 (fr) * | 2000-09-15 | 2003-03-07 | Theramex | Nouvelles compositions estro-progestatives topiques a effet systemique |
EP1390040B1 (en) | 2001-05-18 | 2007-01-03 | Pantarhei Bioscience B.V. | Pharmaceutical composition for use in hormone replacement therapy |
ATE449606T1 (de) | 2001-05-23 | 2009-12-15 | Pantarhei Bioscience Bv | Tetrahydroxylierte estrogen enthaltendes arzneistoffverabreichungssystem zur verwendung in hormonalen kontrazeption |
DE60223795T2 (de) | 2001-05-23 | 2008-11-27 | Pantarhei Bioscience B.V. | Tetrahydroxyliertes Östrogen enthaltendes Arzneistoffverabreichungssystem zur Verwendung in der hormonalen Kontrazeption |
ES2278925T3 (es) | 2001-11-15 | 2007-08-16 | Pantarhei Bioscience B.V. | Uso de compuestos estrogenicos en combinacion con compuestos progestogenicos en terapias de sustitucion hormonal. |
CN1691947B (zh) | 2002-06-11 | 2011-11-23 | 潘塔希生物科学股份有限公司 | ***成分在制备用于治疗或预防免疫介导的疾病中的应用以及包含所述***成分的药物组合物 |
WO2003103685A1 (en) | 2002-06-11 | 2003-12-18 | Pantarhei Bioscience B.V. | A method of treating human skin and a skin care composition for use in such a method |
EP1515725A4 (en) * | 2002-06-25 | 2005-09-21 | Wyeth Corp | USE OF CYCLOTHIOCARBAMATE DERIVATIVES IN THE TREATMENT OF HORMONE-RELATED ILLNESSES |
PT1526856E (pt) | 2002-07-12 | 2008-04-11 | Pantarhei Bioscience Bv | Composição farmacêutica que compreende derivados do estretol para ser utilizada no tratamento do cancro |
SI1556058T1 (sl) | 2002-10-23 | 2008-02-29 | Pantarhei Bioscience Bv | Farmacevtski sestavki, ki obsegajo estetrolne derivate, za uporabo pri zdravljenju raka |
CA2674325A1 (en) | 2007-01-08 | 2008-07-17 | Pantarhei Bioscience B.V. | Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method |
CN107007611B (zh) * | 2017-06-02 | 2020-04-14 | 上海市计划生育科学研究所 | 醋酸诺美孕酮在制备治疗子宫内膜癌的药物中的应用 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4826831A (en) | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
JPS61243059A (ja) | 1985-04-19 | 1986-10-29 | Konishi Kagaku Kogyo Kk | 高純度4,4′−ジヒドロキシジフエニルスルホンの製造法 |
DE3603644A1 (de) | 1986-02-06 | 1987-08-13 | Metabowerke Kg | Spannfutter zum einspannen von bohrern oder schlagbohrern |
ZA87332B (en) | 1986-02-27 | 1987-08-26 | Warner Lambert Co | Compositions containing fixed combinations |
US5208225A (en) * | 1986-02-27 | 1993-05-04 | Warner-Lambert Company | Compositions containing fixed combinations |
US5108995A (en) | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
CA1332227C (en) | 1987-09-24 | 1994-10-04 | Robert F. Casper | Oral contraceptive formulation |
AU630334B2 (en) | 1987-09-24 | 1992-10-29 | Jencap Research Ltd. | Hormone preparations for hormone replacement therapy and contraceptive method |
US5256421A (en) | 1987-09-24 | 1993-10-26 | Jencap Research Ltd. | Hormone preparation and method |
US5276022A (en) | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
HUT52382A (en) | 1988-03-14 | 1990-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case |
IE71203B1 (en) | 1990-12-13 | 1997-02-12 | Akzo Nv | Low estrogen oral contraceptives |
FR2695826B1 (fr) | 1992-09-21 | 1995-01-06 | Theramex | Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention. |
US5554601A (en) | 1993-11-05 | 1996-09-10 | University Of Florida | Methods for neuroprotection |
US5552394A (en) | 1994-07-22 | 1996-09-03 | The Medical College Of Hampton Roads | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
US6613757B1 (en) | 1994-09-22 | 2003-09-02 | Board Of Regents, The University Of Texas System | Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
SE9403389D0 (sv) | 1994-10-06 | 1994-10-06 | Astra Ab | Pharmaceutical composition containing derivattves of sex hormones |
FR2737411B1 (fr) | 1995-08-01 | 1997-10-17 | Theramex | Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques |
KR19990036033A (ko) | 1995-08-01 | 1999-05-25 | 한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 | 리포소옴성 올리고뉴클레오티드 조성물 |
US5888543A (en) | 1996-07-26 | 1999-03-30 | American Home Products Corporation | Oral contraceptives |
WO2001030355A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation |
FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
DE19739916C2 (de) | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
FR2776191B1 (fr) * | 1998-03-23 | 2002-05-31 | Theramex | Composition hormonale topique a effet systemique |
WO2001030356A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
FR2814074B1 (fr) * | 2000-09-15 | 2003-03-07 | Theramex | Nouvelles compositions estro-progestatives topiques a effet systemique |
WO2003041741A1 (en) * | 2001-11-15 | 2003-05-22 | Pantarhei Bioscience B.V. | Method of preventing or treating benign gynaecological disorders |
US20080242650A1 (en) | 2007-03-26 | 2008-10-02 | Jean-Louis Thomas | Oral contraceptive regimen |
-
1999
- 1999-10-25 WO PCT/FR1999/002588 patent/WO2001030356A1/fr active Application Filing
- 1999-10-29 US US09/423,109 patent/US8168619B1/en not_active Expired - Fee Related
-
2000
- 2000-10-24 MX MXPA02004084A patent/MXPA02004084A/es active IP Right Grant
- 2000-10-24 IL IL14895300A patent/IL148953A0/xx active IP Right Grant
- 2000-10-24 DE DE60017281T patent/DE60017281T2/de not_active Expired - Lifetime
- 2000-10-24 ES ES00971476T patent/ES2235967T3/es not_active Expired - Lifetime
- 2000-10-24 AP APAP/P/2002/002475A patent/AP1625A/en active
- 2000-10-24 CN CNB008147841A patent/CN100553637C/zh not_active Expired - Fee Related
- 2000-10-24 KR KR1020027005259A patent/KR100623788B1/ko active IP Right Grant
- 2000-10-24 DK DK00971476T patent/DK1227814T3/da active
- 2000-10-24 HU HU0203721A patent/HU229382B1/hu not_active IP Right Cessation
- 2000-10-24 EP EP00971476A patent/EP1227814B1/fr not_active Expired - Lifetime
- 2000-10-24 PT PT00971476T patent/PT1227814E/pt unknown
- 2000-10-24 BR BRPI0014979A patent/BRPI0014979B8/pt not_active IP Right Cessation
- 2000-10-24 JP JP2001532775A patent/JP5036943B2/ja not_active Expired - Fee Related
- 2000-10-24 NZ NZ518145A patent/NZ518145A/en not_active IP Right Cessation
- 2000-10-24 RU RU2002113652/15A patent/RU2261106C2/ru not_active IP Right Cessation
- 2000-10-24 CA CA002389025A patent/CA2389025C/fr not_active Expired - Lifetime
- 2000-10-24 AT AT00971476T patent/ATE286400T1/de active
- 2000-10-24 WO PCT/FR2000/002939 patent/WO2001030357A1/fr active IP Right Grant
- 2000-10-24 AU AU10326/01A patent/AU777704B2/en not_active Ceased
- 2000-10-24 PL PL356847A patent/PL199848B1/pl unknown
- 2000-10-24 CZ CZ20021427A patent/CZ303248B6/cs not_active IP Right Cessation
- 2000-10-24 OA OA1200200119A patent/OA12072A/fr unknown
- 2000-10-24 SI SI200030615T patent/SI1227814T1/xx unknown
-
2002
- 2002-04-01 IL IL148953A patent/IL148953A/en unknown
- 2002-04-25 NO NO20021949A patent/NO327973B1/no not_active IP Right Cessation
- 2002-04-29 ZA ZA200203398A patent/ZA200203398B/en unknown
-
2003
- 2003-02-06 HK HK03100875.7A patent/HK1050472B/zh not_active IP Right Cessation
-
2012
- 2012-04-17 US US13/448,953 patent/US9084796B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0204137A2 (hu) | Fulvesztrantot tartalmazó gyógyászati készítmény | |
HUP0203721A2 (hu) | Új hormonkészítmény és alkalmazása | |
MY118371A (en) | Tetrahydrolipstatin containing compositions | |
NO993520D0 (no) | Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon | |
MY126555A (en) | Oral pharmaceutical extended release dosage form | |
HK1050839A1 (en) | Use of pharmaceutical compositions comprising oxcarbazepine in the fasted state | |
AU5587690A (en) | Treatment of postmenopausal disorders | |
BG105568A (en) | Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent | |
HUP0000138A2 (hu) | Szabályozott hatóanyag-leadású opioid analgetikumokat tartalmazó gyógyászati készítmények | |
HUP0003848A2 (hu) | Budesonid és formoterol új alkalmazása | |
CA2227887A1 (en) | Pharmaceutical compositions of conjugated estrogens and methods for their use | |
PT1126828E (pt) | Administração oral de análogos de adenosina | |
TW200514560A (en) | Pharmaceutical formulation for contraception and hormone-replacement therapy | |
HU229443B1 (en) | Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use | |
BG105173A (en) | Novel salt form of pantoprazole | |
EE04997B1 (et) | Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine | |
WO1994008613A3 (en) | Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy | |
HUP0105481A2 (hu) | Klaritromicint vagy származékait tartalmazó gyógyászati készítmények és eljárás előállításukra, valamint alkalmazásuk | |
WO2002011694A3 (en) | COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS | |
BG105570A (en) | Pharmaceutical compositions for modified release insulin sensitiser | |
AR009113A1 (es) | UN PRODUCTO ANTICONCEPTIVO PARA DETENER LA OVULACIoN EN MUJERES DURANTE SU PERIODO DE ACTIVIDAD OVÁRICA | |
HUP9900612A2 (hu) | Új hormonális gyógyászati készítmények, valamint a készítmények alkalmazása ösztrogénpótlásra | |
HUP0004461A2 (hu) | Apoliprotein B kiválasztást/mikroszomális trigliceridtranszfer-proteint gátló anyag alkalmazása gyógyászati készítmények előállítására és a fenti gyógyászati készítmények | |
UA81387C2 (en) | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive | |
CA2361081A1 (en) | Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB9A | Succession in title |
Owner name: THERAMEX HQ UK LIMITED, GB Free format text: FORMER OWNER(S): LABORATOIRE THERAMEX, MC; TEVA PHARMACEUTICALS INTERNATIONAL GMBH, CH |
|
MM4A | Lapse of definitive patent protection due to non-payment of fees |